Diabetes Genomics and Analysis Core
糖尿病基因组学和分析核心
基本信息
- 批准号:10669005
- 负责人:
- 金额:$ 17.9万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAbbreviationsAdoptionArchitectureAwardBioinformaticsBiologicalBiological AssayCell NucleusChIP-seqChromatinChromatin StructureConsultationsDNA methylation profilingDataData AnalysesDevelopmentDiabetes MellitusEncapsulatedEquipmentEvolutionGene Expression ProfilingGeneticGenomeGenomic DNAGenomic medicineGenomicsGoalsGrowthHealthHigh-Throughput Nucleotide SequencingHigh-Throughput RNA SequencingHourHumanHuman MicrobiomeIndividualInformaticsInsulin-Dependent Diabetes MellitusLaboratoriesLibrariesModernizationNon-Insulin-Dependent Diabetes MellitusNucleic AcidsNucleotidesPreparationRegulatory ElementResearchResearch DesignResearch PersonnelResourcesServicesTechniquesTechnologyTrainingTransposaseUniversitiesanalytical methodapplied biomedical researchchromatin immunoprecipitationcomputerized toolscostcost effectivedesignexperimental studygenome sequencinghuman diseaseinnovationisletmedical schoolsmembernew technologynext generation sequencingpersonalized medicineportabilityprogramssingle cell sequencingsingle-cell RNA sequencingtooltranscriptome sequencing
项目摘要
DIABETES GENOMICS AND ANALYSIS CORE (DGAC): PROJECT SUMMARY/ABSTRACT
The SDRC Diabetes Genomics and Analysis Core (DGAC) supports the genomic research of SDRC
investigators through access to next-generation sequencing and modern bioinformatics analysis. Nucleotide
sequencing has become essential for formulating and resolving crucial biological questions in many contexts,
like diabetes. This includes determining the underlying causes of human diseases to monitoring gene
expression, elucidating regulatory networks and exploring organismal diversity that may impact human health,
like human microbiomes. Researchers use this technology increasingly for an ever-broadening range of
applications to detect and characterize nucleic acid molecules (RNA and DNA). The overall goal of the DGAC
is to provide SDRC investigators with a next-generation sequencing facility composed of state-of-the-art
laboratory, computational facilities and engaged bio-informatics support. The DGAC is committed to providing
SDRC laboratories with the expertise and technical support necessary to realize the potential of next-
generation sequencing in a cost-effective manner regardless of their existing expertise in genomics. This
includes active evolution of core services, like the development of the wildly popular bio-informatics ‘Office
Hours’ and consulting services: thus, the DGAC helps SDRC members from ‘start to finish’ with their
genomics-based experiments. We will continue to offer a complete package of services ranging from study
design consultation, library preparation services, access to sequencing technologies, and analysis and
interpretation of sequencing data. SDRC laboratories can leverage the technologies and expertise of the
DGAC to overcome cost-prohibitive barriers of entry into genomics. Based on the strengths of the DGAC and
its contributions, the specific aims are to provide SDRC core users guidance with design of their next-
generation sequencing projects, access to a broad range of nucleotide library preparation services, access to
sequencing services with modern sequencing technologies, and support with data analysis and interpretation
of their sequencing projects. The proven strengths of the DGAC in these techniques will continue to provide
investigators with a unique opportunity to effectively apply powerful research approaches that would be
prohibitively difficult for individual laboratories to develop. The DGAC serves as an invaluable resource for the
SDRC, providing investigators with the next-generation sequencing expertise and training necessary to
examine the genome at a level of access and subsidized cost for SDRC members that is not achievable at
Stanford without this core. The DGAC will also serve SDRC members at UC Berkeley and UC Davis, including
those supported through the proposed Regional Pilot & Feasibility Award expansion. Based on growth of the
SDRC membership, evolution of exciting new technologies, and increasing membership demand for bio-
informatic support and analysis, we anticipate growth in use of the specialized and unique DGAC services in
the coming years.
糖尿病基因组学和分析核心(DGAC):项目摘要/摘要
SDRC糖尿病基因组学和分析核心(DGAC)支持SDRC的基因组研究
通过获取下一代测序和现代生物信息学分析的研究人员。核苷酸
在许多情况下,测序对于在许多情况下制定和解决关键的生物学问题至关重要,
喜欢糖尿病。这包括确定人类疾病监测基因的根本原因
表达,阐明监管网络并探索可能影响人类健康的有机多样性,
像人类微生物。研究人员越来越多地使用这项技术
检测和表征核酸分子(RNA和DNA)的应用。 DGAC的总体目标
是为SDRC调查人员提供由最先进的下一代测序设施
实验室,计算设施和敬业的生物信息学支持。 DGAC致力于提供
SDRC实验室具有实现下一步潜力所必需的专业知识和技术支持
无论其现有基因组学专业知识如何,以具有成本效益的方式进行生成测序。这
包括核心服务的积极演变,例如开发广受欢迎的生物信息学的办公室
小时和咨询服务:因此,DGAC帮助SDRC成员从“开始到结束”。
基于基因组学的实验。我们将继续提供一套完整的服务,包括学习
设计咨询,图书馆准备服务,访问测序技术以及分析以及
测序数据的解释。 SDRC实验室可以利用
DGAC以克服基因组学入口成本障碍的障碍。基于DGAC的优势和
它的贡献是,具体的目的是通过设计其下一步的SDRC核心用户指导
生成测序项目,访问广泛的核苷酸图书馆准备服务,访问
通过现代测序技术进行测序服务,并通过数据分析和解释支持
他们的测序项目。这些技术中DGAC的可靠优势将继续提供
具有独特机会的研究人员有效地采用强大的研究方法
个人实验室很难发展。 DGAC充当了无价的资源
SDRC,为调查人员提供了必要的下一代测序专业知识和培训
检查SDRC成员的访问水平和补贴成本的基因组,这是无法实现的
没有这个核心的斯坦福。 DGAC还将为UC Berkeley和UC Davis的SDRC成员提供服务,包括
那些通过拟议的区域飞行员和可行性奖扩展的支持。基于
SDRC成员资格,令人兴奋的新技术的发展以及对生物的成员需求的增加
信息丰富的支持和分析,我们预计使用专业和独特的DGAC服务的增长
未来几年。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HASSAN CHAIB其他文献
HASSAN CHAIB的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HASSAN CHAIB', 18)}}的其他基金
相似海外基金
Optimizing Care for Older Adults through Thyroid Hormone Deprescribing
通过减少甲状腺激素处方来优化老年人的护理
- 批准号:
10733478 - 财政年份:2023
- 资助金额:
$ 17.9万 - 项目类别:
Development of an HPV stigma assessment scale and a stigma-reducing intervention to improve cervical cancer prevention in El Salvador
制定 HPV 耻辱评估量表和减少耻辱干预措施,以改善萨尔瓦多的宫颈癌预防
- 批准号:
10844859 - 财政年份:2023
- 资助金额:
$ 17.9万 - 项目类别:
Identifying Successful Strategies for Implementing Team-Based Home Blood Pressure Monitoring in Primary Care
确定在初级保健中实施基于团队的家庭血压监测的成功策略
- 批准号:
10701721 - 财政年份:2022
- 资助金额:
$ 17.9万 - 项目类别:
Identifying Successful Strategies for Implementing Team-Based Home Blood Pressure Monitoring in Primary Care
确定在初级保健中实施基于团队的家庭血压监测的成功策略
- 批准号:
10474081 - 财政年份:2022
- 资助金额:
$ 17.9万 - 项目类别:
Enabling remote medical physics services for medical accelerator quality assurance through a novel, table-top imaging device
通过新颖的桌面成像设备实现远程医学物理服务,以保证医疗加速器的质量
- 批准号:
10773360 - 财政年份:2021
- 资助金额:
$ 17.9万 - 项目类别: